Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19)

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 10, 2010, Pages 3050-3064

  Muftuoglu, Yagmur ^a   Mustata, Gabriela ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Aromatase; CYP19; Ligand based drug design; Pharmacophore model; Structure based drug design

Indexed keywords

1 (4 FLUOROBENZYL) 3 1 (IMIDAZOLYLMETHYL) 1H INDOLE; 1 (4,4' DICYANOBENZHYDRYL)IMIDAZOLE; 1 (9 PHENYL 9H FLUOREN 9 YL) 1H IMIDAZOLE; 11 BETA, 13 DIHYDRO 10 EPI 8 DEOXYCUMAM BRIN B; 1[(7 FLUORONAPHTH 2 YL)METHYL] 1H IMIDAZOLE; 3 [IMIDAZOL 1 YL (4 NITRO PHENYL)METHYL]CHROMEN 4 ONE; 5 [(4 CHLOROPHEN YL)(1H IMIDAZOL 1 YL)METHYL]1H INDOLE; 5 [(IMIDAZOL 1 YL)METHYL] 5,6,7,8 TETRAHYDROQUINOLINE; 5 BROMO 1 ETHYL 3 [(IMIDAZOLYL)(PHENYL)METHYL]INDOLE; 6 [1 (IMIDAZOL 1 YL) 1 PHENYLMETHYL] 3 METHYL 1,3 BENZOTHIAZOL 2(3H)ONE; 7,4' DIHYDROXYFLAVONE; 9 HYDROXY 7,8 BENZOFLAVONE; ALPHA NAPHTHOFLAVONE; ANASTROZOLE; ANDROSTENEDIONE; APIGENIN; AROMATASE; AROMATASE INHIBITOR; CGS 18320 B; CHRYSIN; CLOTRIMAZOLE; FADROZOLE; LETROZOLE; LIAROZOLE; MICONAZOLE; MR 16089; MR 20494; MR 50492; N [2 (4' NITROPHENYL)ETHYL]IMIDAZOLE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VOROZOLE;

ARTICLE; BREAST CANCER; DRUG EFFICACY; DRUG STRUCTURE; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME STRUCTURE; ENZYME SUBSTRATE COMPLEX; IC 50; PHARMACOPHORE; PROTEIN TARGETING; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ANTINEOPLASTIC AGENTS; AROMATASE; AROMATASE INHIBITORS; BINDING SITES; BREAST NEOPLASMS; COMPUTER SIMULATION; DRUG DESIGN; FEMALE; HUMANS; MODELS, CHEMICAL; MODELS, MOLECULAR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77952101961     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2010.03.113     Document Type: Article

References (75)

1. Cancer Facts & Figures 2008. American Cancer Society. 2009.
2. Brueggemeier R.W., Hackett J.C., and az-Cruz E.S. Endocr. Rev. 26 (2005) 331
3. Meunier B., de Visser S.P., and Shaik S. Chem. Rev. 104 (2004) 3947
4. Simpson E.R., Mahendroo M.S., Means G.D., Kilgore M.W., Hinshelwood M.M., Graham-Lorence S., Amarneh B., Ito Y., Fisher C.R., and Michael M.D. Endocr. Rev. 15 (1994) 342
5. Miller W.R. Cancer Treat. Rev. 23 (1997) 171
6. Miller W.R., Bartlett J., Brodie A.M., Brueggemeier R.W., di S.E., Lonning P.E., Llombart A., Maass N., Maudelonde T., Sasano H., and Goss P.E. Oncologist 13 (2008) 829
7. Brodie A.M., and Njar V.C. J. Steroid Biochem. Mol. Biol. 66 (1998) 1
8. Simpson E.R., and Davis S.R. Endocrinology 142 (2001) 4589
9. Brodie A., Sabnis G., and Jelovac D. J. Steroid Biochem. Mol. Biol. 102 (2006) 97
10. Castellano S., Stefancich G., Ragno R., Schewe K., Santoriello M., Caroli A., Hartmann R.W., and Sbardella G. Bioorg. Med. Chem. 16 (2008) 8349
11. Colozza M., Califano R., Minenza E., Dinh P., and Azambuja E. Mini-Rev. Med. Chem. 8 (2008) 564
12. Dutta U., and Pant K. Med. Oncol. 25 (2008) 113
13. Eisen A., Trudeau M., Shelley W., Messersmith H., and Pritchard K.I. Cancer Treat. Rev. 34 (2008) 157
14. Gobbi S., Cavalli A., Bisi A., and Recanatini M. Curr. Top. Med. Chem. 8 (2008) 869
15. Jackson T., Woo L.W., Trusselle M.N., Purohit A., Reed M.J., and Potter B.V. ChemMedChem 3 (2008) 603
16. Osborne C., and Tripathy D. Annu. Rev. Med. 56 (2005) 103
17. Osborne C.K., and Schiff R. J. Steroid Biochem. Mol. Biol. 95 (2005) 183
18. Recanatini M., and Cavalli A. Bioorg. Med. Chem. 6 (1998) 377
19. Recanatini M., Cavalli A., and Valenti P. Med. Res. Rev. 22 (2002) 282
20. Spinelli G.P., Tomao F., Miele E., Pasciuti G., Russillo M., and Tomao S. Recenti Prog. Med. 99 (2008) 34
21. Hong Y., Yu B., Sherman M., Yuan Y.C., Zhou D., and Chen S. Mol. Endocrinol. 21 (2007) 401
22. Neves M.A., Dinis T.C., Colombo G., and Sae Melo M.L. J. Med. Chem. 52 (2009) 143
23. Geisler J., and Lonning P.E. Clin. Cancer Res. 11 (2005) 2809
24. A Report From Breast Cancer Action. SIDE EFFECTS REVISITED: Women's Experiences With Aromatase Inhibitors. A Report From Breast Cancer Action. 2008.
25. Favia A.D., Cavalli A., Masetti M., Carotti A., and Recanatini M. Proteins 62 (2006) 1074
26. Karkola S., Holtje H.D., and Wahala K. J. Steroid Biochem. Mol. Biol. 105 (2007) 63
27. Loge C., Le B.M., Marchand P., Robert J.M., Le B.G., Palzer M., and Hartmann R.W. J. Enzyme Inhib. Med. Chem. 20 (2005) 581
28. Murthy J.N., Nagaraju M., Sastry G.M., Rao A.R., and Sastry G.N. J. Comput. Aided Mol. Des. 19 (2005) 857
29. Cavalli A., Greco G., Novellino E., and Recanatini M. Bioorg. Med. Chem. 8 (2000) 2771
30. Janicke F. Anti-Cancer Drugs 19 (2008) S7
31. Neves M.A., Dinis T.C., Colombo G., and Sae Melo M.L. ChemMedChem 2 (2007) 1750
32. Numazawa M., Komatsu S., Tominaga T., and Yamashita K. Chem. Pharm. Bull. (Tokyo) 56 (2008) 1304
33. Ghosh D., Griswold J., Erman M., and Pangborn W. Nature 457 (2009) 219
34. Chemical Computing Group. Pharmacophore Modeling. Chemical Computing Group. 2008.
35. Wolber G., and Langer T. J. Chem. Inf. Model. (2005)
36. Wolber G. Drug Discovery Today (2008)
37. ACD/ChemSketch: Version 8.0 for Microsoft Windows. Advanced Chemistry Development, Inc. 2004.
38. Goss P.E. Breast Cancer Res. Treat. 49 (1998) S59
39. Hartmann R.W., Bayer H., Grun G., Sergejew U.B., and Mitrenga M. J. Med. Chem. 38 (1995) 2103
40. Cavalli A., Bisi A., Bertucci C., Rosini C., Paluszcak A., Gobbi S., Giorgio E., Rampa A., Belluti F., Piazzi L., Valenti P., Hartmann R.W., and Recanatini M. J. Med. Chem. 48 (2005) 7282
41. Le B.M., Marchand P., Duflos M., Delevoye-Seiller B., Piessard-Robert S., Le B.G., Hartmann R.W., and Palzer M. Arch. Pharm. 330 (1997) 141
42. Bossche H.V. J. Steroid Biochem. Mol. Biol. 43 (1992) 1003
43. Leonetti F., Favia A.D., Rao A.R., Aliano R., Paluszcak A., Hartmann R.W., and Carotti A. J. Med. Chem. 47 (2004) 6792
44. Simpson E.R., and Dowsett M. Endocr. Soc. (2002)
45. Hackett, J. C. PhD Thesis: Computational Investigations of Cytochrome P450 Aromatase Catalysis and Biological Evaluation of Isoflavone Aromatase Inhibitors. The Ohio State University. 2004.
46. Gobbi S., Cavalli A., Negri M., Schewe K., Belluti F., Piazzi L., Hartmann R.W., Recanatini M., and Bisi A. J. Med. Chem. 50 (2007) 3420
47. Nativelle-Serpentini C., Moslemi S., Yous S., Park C.H., Lesieur D., Sourdaine P., and Seralini G. J. Enzyme Inhib. Med. Chem. 19 (2004) 119
48. Sonnet P., Dallenmagne P., Guillon J., Enguehard C., Stiebing S., Tanguy J., Bureau R., Rault S., Auvray P., Moslemi S., Sourdaine P., and Seralini G. Bioorg. Med. Chem. 8 (2000) 945
49. Hartmann R.W., Paluszcak A., Lacan F., Ricci G., and Ruzziconi R. J. Enzyme Inhib. Med. Chem. 19 (2004) 145
50. Kellis J.T., and Vickery L.E. Science 225 (1984) 1032
51. Ahmed S., Smith H.J., Nicholls P.J., Whomsley R., and Cariuk P. Drug Des Discov. 13 (1995) 27
52. Jacobs C., Frotscher M., Dannhardt G., and Hartmann R.W. J. Med. Chem. 43 (2000) 1841
53. Recanatini M., Bisi A., Belluti F., Gobbi S., Rampa A., Valenti P., Palzer M., Paluszcak A., and Hartmann R.W. J. Med. Chem. 44 (2001) 672
54. van Meeuwen J.A., Nijmeijer S., Mutarapat T., Ruchirawat S., de Jong P.C., Piersma A.H., and van den Berg M. Toxicol. Appl. Pharmacol. 228 (2008) 269
55. Wolber G., and Langer T. J. Chem. Inf. Model. 45 (2005) 160
56. Wolber G., Seidel T., Bendix F., and Langer T. Drug Discovery Today 13 (2008) 23
57. Koymans L.M.H., Moereels H., and Vanden Bossche H. J. Steroid Biochem. Mol. Biol. 53 (1995) 191
58. Leze M., Le B.M., Pinson P., Paluszcak A., Duflos M., Le B.G., and Hartmann R.W. Bioorg. Med. Chem. Lett. 16 (2006) 1134
59. Jeong H., Shin Y.G., Kim I., and Pezzuto J.M. Arch. Pharm. Res. 22 (1999) 309
60. Mason J.I., Barbara A.M., Ollcott M., and Sheets J.L. Biochem. Pharmacol. 34 (1985) 1087
61. Brueggemeier R.W., Richards J.A., Joomprabutra S., Bhat A.S., and Whetstone J.L. J. Steroid Biochem. Mol. Biol. 79 (2001) 75
62. Blanco J.G., Gill R.R., Alvarez C.I., Patrito L.C., Genti-Raimondi S., and Flury A. FEBS Lett. 409 (1997) 396
63. Sonnet P., Guillon J., Enguehard C., Dallenmagne P., Bureau R., and Rault S. Bioorg. Med. Chem. Lett. 8 (1998) 1041
64. Ibrahim A.R., and Abul-Hajj Y. J. Steroid Biochem. Mol. Biol. 37 (1990) 257
65. Bayer H., Batzl C., Hartmann R.W., and Mannschreck A. J. Med. Chem. 34 (1991) 2685
66. Auvray P., Moslemi S., Sourdaine P., Galopin S., Seralini G., Enguehard C., Dallenmagne P., Bureau R., Sonnet P., and Rault S. Eur. J. Med. Chem. 33 (1998) 451
67. Pouget C., Fagnere C., Basly J.-P., Habrioux G., and Chulia A.J. Bioorg. Med. Chem. Lett. 12 (2002) 2859
68. Adlercreutz H., Bannwart C., Wahala K., Makela T., Brunow G., Hase T., Arosemena P.J., Kellis J.T., and Vickery L.E. J. Steroid Biochem. Mol. Biol. 44 (1993) 147
69. Whomsley R., Fernandez E., Nicholls P.J., Smith H.J., Lombardi P., and Pestellini V. J. Steroid Biochem. Mol. Biol. 44 (1993) 675
70. Hida T., Ishii T., Kanamaru T., and Muroi M. J. Antibiot. 44 (1991) 600
71. Kim Y.-W., Hackett J.C., and Brueggemeier R.W. J. Med. Chem. 47 (2004) 4032
72. Thomsen R., and Christensen M.H. J. Med. Chem. 49 (2006) 3315
73. Gehlhaar, D. K.; Verkhivker, G. Proceedings of the Fourth International Conference o Evolutionary Programming. 1995, pp 615-627.
74. Gehlhaar, D. K.; Bouzida, D. Proceedings of the Seventh International Conference on Evolutionary Programming. 1998; pp 449-461.
75. Yang J.M., and Chen C.C. Proteins 55 (2004) 288